Financial Statements — EXYN
Balance Sheet
(in millions USD)| Metric | Q2
2026 | Q1
2026 |
|---|
| Cash & Equivalents | 4.49 | 7.39 |
| Accounts Receivable | 0.85 | 0.57 |
| Inventory | 1.71 | 1.50 |
| Total Current Assets | 11.22 | 4.53 |
| Property, Plant & Equipment | 0.23 | 0.28 |
| Total Non-current Assets* | 0.53 | 0.62 |
| Total Assets | 11.76 | 5.15 |
| Accounts Payable | 1.18 | 2.00 |
| Total Current Liabilities | 6.10 | 18.60 |
| Long-term Debt | 1.69 | 8.06 |
| Total Non-current Liabilities | 0.08 | 0.88 |
| Total Liabilities | 6.18 | 19.47 |
| Retained Earnings | (86.05) | (79.15) |
| Total Stockholder Equity* | 5.57 | (14.32) |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 |
|---|
| Total Revenue | 0.95 | 1.19 |
| Cost of Revenue | 0.50 | 0.69 |
| Gross Profit | 0.45 | 0.50 |
| Research & Development | 1.36 | 1.21 |
| Selling, General & Admin | 3.02 | 1.96 |
| Total Operating Expenses | 4.57 | 3.38 |
| Operating Income | (4.13) | (2.87) |
| Pretax Income | (6.89) | (3.24) |
| Net Income | (6.89) | (3.24) |
| Basic EPS | (1.55) | (2.45) |
| Diluted EPS | (1.55) | (2.45) |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 |
|---|
| Operating Cash Flow | (5.45) | (1.63) |
| Capital Expenditures | 0.03 | 0.00 |
| Free Cash Flow* | (5.47) | (1.63) |
| Investing Cash Flow | (0.03) | -0.00 |
| Financing Cash Flow | 12.21 | 1.92 |
* Derived from reported values
